Loading…
Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011
Legislative Progress
Introduced
June 16, 2011
Latest Action
June 22, 2011
Primary Sponsor
F. James Sensenbrenner, Jr.Republican(WI)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
37pct
6d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2013 · first_quarter · Health Issues
H.R. 733 & S. 362: Pancreatic Cancer Research & Education Act H.R. 2239: Functional Gastrointestinal & Motility Disorder (FGIMD) Research Enhancement Act H.R. 2108 & S. 1173: Ambulatory Surgical Center Quality & Access Act H.R. 2195 & S. 1203: Medicare Home Infusion Therapy CoverageH.R. 842: The Functional Gastrointestinal and Motility Disorders (FGIMD) Research Enhancement Act H.R. 225: Senate passage of the National Pediatric Research Network Act H.R. 991: The CT Colonography Screening for Colorectal Cancer Act H.R. 1070: The Removing Barriers to Colorectal Cancer Screening Act H.R.: 460: The Patients' Access to Treatments Act
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Health Issues
H.R. 733 & S. 362: Pancreatic Cancer Research & Education Act H.R. 2239: Functional Gastrointestinal & Motility Disorder (FGIMD) Research Enhancement Act H.R. 2108 & S. 1173: Ambulatory Surgical Center Quality & Access Act H.R. 2195 & S. 1203: Medicare Home Infusion Therapy Coverage H.R. 3839: Drug shortage legislation including: The Drug Shortage Prevention Act H.R. 2245 & S. 296: The Preserving Access to Life Saving Medications Act H.R. 3381 & S. 1809: Viral Hepatitis Testing Act H.R. 3198: Supporting Colorectal Examination & Education Now (SCREEN) Act H.R. 912 & S. 494: Colorectal Cancer Prevention, Early Detection, and Treatment Act H.R. 3211 & S. 1865: Patient Access to Medical Innovation Act: humanitarian Device Reform Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Health Issues
H.R. 1080: Pediatric Research Consortia Establishment Act H.R. 2239: Functional Gastrointestinal & Motility Disorders Research Enhancement Act of 2011 S. 3461: National Pediatric Research Network Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Health Issues
H.R. 1080: Pediatric Research Consortia Establishment Act H.R. 2239: Functional Gastrointestinal & Motility Disorders Research Enhancement Act of 2011 S. 3461: National Pediatric Research Network Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Health Issues
H.R. 733 & S. 362: Pancreatic Cancer Research & Education Act H.R. 2239: Functional Gastrointestinal & Motility Disorders (FGIMD) Research Enhancement Act H.R. 2108 & S. 1173: Ambulatory Surgical Center Quality & Access Act H.R. 2195 & S. 1203: Medicare Home Infusion Therapy Coverage H.R. 3839: Drug shortage legislation including: The Drug Shortage Prevention Act H.R. 2245/S.296: The Preserving Access to Life Saving Medications Act H.R. 3381/S. 1809: Viral Hepatitis Testing Act H.R. 3198: Supporting Colorectal Examination & Education Now (SCREEN) Act H.R. 912/S. 494: Colorectal Cancer Prevention, Early Detection, and Treatment Act H.R. 3211/S. 1865: Patient Access to Medical Innovation Act: Humanitarian Device Reform Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Health Issues
H.R .733 & S. 362: Pancreatic Cancer Research & Education Act H.R. 2239: Functional Gastrointestinal & Motility Disorders (FGIMD)Research Enhancement Act H.R. 2108 & S. 1173: Ambulatory Surgical Center Quality & Access Act H.R. 2195 & S. 1203: Medicare Home Infusion Therapy Coverage H.R.3839: Drug shortage legislation including: The Drug Shortage Prevention Act H.R. 2245/S. 296: The Preserving Access to Life Saving Medications Act H.R. 3381/S. 1809: Viral Hepatitis Testing Act H.R. 3198: Supporting Colorectal Examination & Education Now (SCREEN) Act H.R. 912/S. 494: Colorectal Cancer Prevention, Early Detection, and Treatment Act H.R. 3211/S. 1865: Patient Access to Medical Innovation Act: Humanitarian Device Reform Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Health Issues
H.R. 1080: Pediatric Research Consortia Establishment Act H.R. 2239: Functional Gastrointestinal & Motility Disorders Research Enhancement Act of 2011
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Health Issues
H.R. 1080: Pediatric Research Consortia Establishment Act H.R. 2239: Functional Gastrointestinal & Motility Disorders Research Enhancement Act of 2011
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Health Issues
H.R. 733/S. 362: Pancreatic Cancer Research & Education Act H.R. 2239: Functional Gastrointestinal & Motility Disorders (FGIMD) Research Enhancement Act H.R. 2108/S. 1173: Ambulatory Surgical Center Quality & Access Act H.R. 2195/S. 1203: Medicare Home Infusion Therapy Coverage H.R.3839: Drug shortage legislation including: The Drug Shortage Prevention Act H.R. 2245/S. 296: The Preserving Access to Life Saving Medications Act H.R. 3381/S. 1809: Viral Hepatitis Testing Act H.R. 3198: Supporting Colorectal Examination & Education Now (SCREEN) Act H.R. 912/S. 494: Colorectal Cancer Prevention, Early Detection, and Treatment Act H.R. 3211/S. 1865: Patient Access to Medical Innovation Act: Humanitarian Device Reform Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Medical/Disease Research/Clinical Labs
Regenerative Medicines Promotion Act; Gastrointestinal and Motility Disorders Research Enhancement Act (H.R. 2239); depression screening, end stage renal disease;
Client expense: $510,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Treasury, Dept of
2011 · third_quarter · Medical/Disease Research/Clinical Labs
Regenerative Medicines Promotion Act; Gastrointestinal and Motility Disorders Research Enhancement Act (H.R. 2239); depression screening, end stage renal disease;
Client expense: $350,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Treasury, Dept of
2011 · fourth_quarter · Health Issues
HR 1080: Pediatric Research Consortia Establishment Act HR 2239: Functional Gastrointestinal & Motility Disorders Research Enhancement Act of 2011
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Health Issues
HR 1080: Pediatric Research Consortia Establishment Act HR 2239: Functional Gastrointestinal & Motility Disorders Research Enhancement Act of 2011
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Medical/Disease Research/Clinical Labs
Regenerative Medicines Promotion Act; Gastrointestinal and Motility Disorders Research Enhancement Act (H.R. 2239); depression screening, end stage renal disease;
Client expense: $400,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Treasury, Dept of
2011 · second_quarter · Medical/Disease Research/Clinical Labs
Regenerative Medicines Promotion Act; Gastrointestinal and Motility Disorders Research Enhancement Act (H.R. 2239)
Client expense: $315,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Treasury, Dept of
2011 · second_quarter · Health Issues
HR 1080: Pediatric Research Consortia Establishment Act HR 2239: Functional Gastrointestinal & Motility Disorders Research Enhancement Act of 2011
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| CO |
| Elijah E. Cummings | Democratic | MD |
| Elton Gallegly | Republican | CA |
| Gwen Moore | Democratic | WI |
| James P. Moran | Democratic | VA |
| Jesse L. Jackson Jr. | Democratic | IL |
| Maurice D. Hinchey | Democratic | NY |
| Mazie K. Hirono | Democratic | HI |
| Nan A. S. Hayworth | Republican | NY |
| Peter Welch | Democratic | VT |
| Ron Kind | Democratic | WI |
| Susan A. Davis | Democratic | CA |
| Tammy Baldwin | Democratic | WI |